Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis

Hepatology

Volumn 36, Issue 4I, 2002, Pages 978-985

  Kayali, Zeid ^a   Buckwold, Victor E ^b   Zimmerman, Bridget ^a   Schmidt, Warren N ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN;

AGE; ARTICLE; CLINICAL TRIAL; CRYOGLOBULINEMIA; CRYOPRECIPITATE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; HEPATITIS C; HUMAN; INCIDENCE; LIVER CIRRHOSIS; META ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE;

CRYOGLOBULINEMIA; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LOGISTIC MODELS; RISK FACTORS;

EID: 85002153461     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.35620     Document Type: Article

References (44)

1. Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 2000;132:296-305.
2. Poynard T, Bedossa P, Opolon, P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997;349:825-832.
3. Benhamou Y, Bochet M, DiMartino V, Charlotte F, Azfia F, Coutellier A, Vidaud M, et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999;30:1054-1058.
4. Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cechetto A, Alberti A. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994;74:2442-2448.
5. Pascual M, Perrin L, Giostra. E, Schifferi JA. Hepatitis C virus inpatients with cryoglobulinemia type II. J Infect Dis 1990;162:569-570.
6. Dammacco F, Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinemia. Clin Exp Rheum 1991;9:621-624.
7. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-1495.
8. Miescher PA, Huang YP, Izui S. Type II cryoglobulinemia. Semin Hematol 1995;32:80-85.
9. Willson RA. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 1997;92:4-17.
10. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 1997;19:111-129.
11. Pawlotsky JM, Yahia BM, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, Deforges L, et al. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study. Hepatology 1994;19:841-848.
12. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, et al. Cryoglobulinemia in chtonic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 1994;106:1291-1300.
13. Schmidt WN, Stapleton JT, La Brecque DR, Mitros F, Kirby PA, Philips MJ, Brashear DL. Hepatitis C Virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology. Hepatology 2000;31:737-743.
14. Ramos-Casals M, Gatcia-Carrasco M, Font J, Cervera. R, Font J. Mixed cryoglobulinemia: new concepts. Lupus 2000;9:83-91.
15. Brouet J, Clauvel J, Danon F, Klein M, Selgimen M, Biologic and clinical significance of cryoglobulins. Am J Med 1974;57:775-788.
16. Casaril M, Capra F, Gabrielli GB, Bassi A, Squarzoni S, Dagradi R, De Maria E, et al. Cryoglobulinemia in hepatitis C virus chronic active hepatitis: effects of interferon-alfa therapy. J Interferon Cytokine Res 1996;16:585-588.
17. Akriviadis EA, Xanthakis I, Navrozidou C, Papadopoulos A. Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha. J Clin Gastroenterol 1997;25:612-618.
18. Hartmann H, Schott P, Polzien F, Mihm S, Uy A, Kaboth U, Pardowitz I, et al. Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates. Z Gastroenterol 1995;33:643-650.
19. Tanaka K, Aiyama T, Imai J, Morishita Y, Fukatsu T, Kakumu S. Serum cryoglobulin and chronic hepatitis C virus disease among Japanese patients. Am J Gastroenterol 1995;90:1847-1852.
20. Polzien F, Schott P, Mihm S, Ramadori G, Hartmann H. Interferon alfa treatment of hepatitis C virus-associated mixed cryoglobulinemia. J Hepatol 1997;27:63-71.
21. Agnello V. Mixed cryoglobulinemia after hepatitis C virus: more or less ambiguity. Ann Rheumatic Dis 1998;57:701-702.
22. Adinolfi LE, Utili R, Attanasio V, Zampino R, Ragone E, Tripodi MF, Ruggiero G. Epidemiology, clinical spectrum, and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study. Ital J Gastroenterol 1996;28:1-9.
23. Wang MC, Bushman BJ. Integrating results through meta-analytic review using SAS Software, Chapter 4: Combining Effect-Size Estimates Based on Categorical Data. Cary, NC: SAS Institute Inc., 1999:108-142.
24. Normand Sharon-Lise T. Tutorial in Biostatistics Meta-Analysis: formulating, evaluating, combining, and reporting. Stat Med 1999;18:321-359.
25. Adinolfi LE, Utili R, Zampino R, Ragone E, Mormone G, Ruggiero G. Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia. Eur J Gastroenterol Hepatol 1997;9:1067-1072.
26. Fayyazi A, Schott P, Hartmann H, Mihm S, Middel P, Ramadori G, Radzun HJ. Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia. Z Gastroenterol 1997;35:921-928.
27. Hwang SJ, Lee SD, Li CP, Lu RH, Chan CY, Wu JC. Clinical study of cryoglobulinaemia in Chinese patients with chronic hepatitis C. J Gastroenterol Hepatol 1997;12:513-517.
28. Donada C, Crucitti A, Donadon V, Tommasi L, Zanette G, Crovatto M, Santini GF, et al. Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia. J Viral Hepat 1998;5:179-185.
29. Lee YH, Ji JD, Yeon JE, Byun KS, Lee CH, Song GG. Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection. Ann Rheum Dis 1998;57:728-731.
30. Perniola R, De Rinaldis C, Accogli E, Lobreglio G. Prevalence and clinical features of cryoglobulinaemia in multitransfused β-thalassanemia patients. Ann Rheum Dis 1999;58:698-702.
31. Horcajada JP, Garcia-Bengoechea M, Cilla G, Etxaniz P, Cuadrado E, Arenas JI. Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes. Ann Med 1999;31:352-358.
32. Cresta P, Musset L, Cacoub L, Frangeul L, Vitour D, Poynrd T, Opolon P, et al. Response to interferon alfa treatment and disappearance of cryoglobulinemia in patients infected by hepatitis C virus. Gut 1999;45:122-128.
33. Calleja LJ, Albillos A, Moreno-Otero R, Rossi I, Domper F, Yebra M, et al. Sustained response to interferon alfa plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinemia. Aliment Pharmacol Ther 1999;13:1179-1186.
34. Nomura H, Ogo T, Rikimaru N, Uneo S, Kakuno T, Okamoto O, Shiraishi G, et al. Hepatitis C virus-related liver damage is related to cold activation of complement. J Clin Gastroenterol 1997;25:529-534.
35. Wong VS, Egner W, Elsey T, Brown D, Alexander GJ. Incidence, character and clinical relevance of mixed cryoglobulinemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996;104:25-31.
36. Crovatto M, Ceselli S, Mazzaro C, Modolo ML, Martelli P, Mazzi G, Pozzato G, et al. HCV genotypes and cryoglobulinemia. Clin Exp Rheumatol 1995;13(Suppl):S79-S82.
37. Frangeul L, Musset L, Cresta P, Cacoub P, Huraux JM, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C with and without cryoglobulinemia. J Hepatol 1996;25:427-432.
38. Liaw YF, Lee CS, Tsai SL, Liaw BW, Chen TC, Sheen IS, Chu CM. T-cell mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995;22:1368-1373.
39. Cerny A, Chisari FV. Immunological aspects of HCV infection. Intervirology 1994;37:119-125.
40. Friedman S. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med 1993;328:1828-1835.
41. Freeman AJ, Dore GJ, Law MG, Thorpe M, Overbeck JV, Lloyd AR, Marinos G, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001 1;34:809-816.
42. D'Amico G, Fornasieri A. Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 1995;25:361-369.
43. Schmidt WN, LaBrecque D, Voigt M, Stapleton J, Rayhill J, Wen F, Perino-Phillips MJ, et al. Combination antiviral therapy in patients with chronic hepatitis C and cryoglobulinemia [Abstract]. Hepatology 2001;34(Part 2):421A.
44. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992;567-571.